Cheng, Qiang http://orcid.org/0000-0002-5213-5084
Wei, Tuo http://orcid.org/0000-0002-2823-9721
Farbiak, Lukas
Johnson, Lindsay T. http://orcid.org/0000-0002-4563-5486
Dilliard, Sean A.
Siegwart, Daniel J. http://orcid.org/0000-0003-3823-1931
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB025192-01A1, R01 EB025192-01A1, R01 EB025192-01A1, R01 EB025192-01A1, R01 EB025192-01A1)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
Article History
Received: 4 December 2019
Accepted: 19 February 2020
First Online: 6 April 2020
Competing interests
: D.J.S., Q.C., T.W. and the Reagents of the University of Texas System have filed patent applications on SORT and related technologies. D.J.S. is a co-founder of ReCode Therapeutics, which has licensed intellectual property from UT Southwestern.